江苏太平洋美诺克生物药业

Jiangsu Pacific Meinuoke Biopharmaceutical is a biopharmaceutical company based in Changzhou, China, specializing in the research, development, and commercial-scale manufacturing of recombinant protein drugs and monoclonal antibodies. The company utilizes proprietary high-efficiency expression platforms to develop a diverse pipeline of biologics, including recombinant human serum albumin, insulin analogs, and biosimilars for autoimmune diseases. With a focus on endocrinology, immunology, and oncology, Meinuoke operates advanced GMP-compliant facilities designed for large-scale production. The organization aims to address critical healthcare needs by providing high-quality, cost-effective biological therapies for both domestic and international markets.